ÇмúÇà»ç

Korean Society of Gastrointestinal Cancer Research

Çмú´ëȸ/¿¬¼ö°­ÁÂ

´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Á¦20ȸ Ãá°èÇмú´ëȸ



icon ÇÁ·Î±×·¥ ¾È³»

Á¦20ȸ Ãá°èÇмú´ëȸ

Date

2024³â 4¿ù 12ÀÏ (Åä)

Venue

½ºÀ§½º±×·£µåÈ£ÅÚ 2Ãþ ±×·£µåº¼·ë

Official Language

Çѱ¹¾î (IASGO SESSION ¿µ¾î ÁøÇà)

Important Dates

ÃÊ·ÏÁ¦Ãâ ¸¶°¨ : 2025³â 2¿ù 28ÀÏ (±Ý)±îÁö
»çÀüµî·Ï ¸¶°¨ : 2025³â 4¿ù 6ÀÏ (ÀÏ)±îÁö


Program

´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Á¦20ȸ Ãá°èÇмú´ëȸ
Hall A
08:30-09:00 µî·Ï
09:00-09:10 Àλ縻 ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ ȸÀå ÀÌ¿ìÁø(±¹¸³¾Ï¼¾ÅÍ)
Session I Advances in Gastric and Esophageal Cancer Immunotherapy: What¡¯s New on the Horizon? ¹®Á¤¼· (ÀÎÁ¦ÀÇ´ë), ±èÁöÇö (¿¬¼¼ÀÇ´ë)
09:10-09:30 Current clinical guidelines for metastatic/recurrent gastric cancer ¹®Èñ¼® (Ãæ³²ÀÇ´ë)
09:30-09:50 Current clinical guidelines for metastatic/recurrent esophageal cancer ±è¼ºÀº (°í½ÅÀÇ´ë)
09:50-10:10 New emerging biomarker and immunotherapy in gastric cancer ÃÖÁ¤À± (°í·ÁÀÇ´ë)
10:10-10:30 New emerging biomarker and immunotherapy in esophageal cancer ¿ì°í¿î (µ¿±¹ÀÇ´ë Ç÷¾×Á¾¾ç³»°ú)
10:30-10:50 Coffee Break
Session II IASGO Joint Session: Debate Issues on Lower Gastrointestinal Neoplasm Kyoichi Takaori (Nagahama City Hospital, Japan), Seun Ja Park (Kosin univ., Korea)
10:50-11:10 Bevacizumab in obstructive metastatic colorectal cancer: A real challenge to stenting? Soo-Young Na (Catholic Univ., Korea)
11:10-11:30 Bevacizumab in obstructive metastatic colorectal cancer: A real challenge to surgery? Been-Ren Lin (Nat'l Taiwan Univ., Taiwan)
11:30-11:50 Optimal management of recurrent or incompletely resected rectal neuroendocrine tumors: Timing for endoscopic resection Seong Jung Kim (Chosun univ., Korea)
11:50-12:10 Optimal management of recurrent or incompletely resected rectal neuroendocrine tumors: Timing for surgical resection Emile Tan (Singapore General Hospital, Singapore)
Luncheon Symposium I ÀÌ¿ìÁø (±¹¸³¾Ï¼¾ÅÍ)
12:10-12:40 Advancing CCA treatment: Integrating pemigatinib into clinical practice ¹é¿ìÇö (¼­¿ïÀÇ´ë)
12:40-13:20 ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ ÃÑȸ
Session III Bio Big Data for Precision Medicine in Gastrointestinal Oncology ¼Û½Ã¿µ (¿¬¼¼ÀÇ´ë), ³²¼ö¿¬ (°æºÏÀÇ´ë)
13:20-13:40 Understanding bio big data: Concepts and basic structure À̺´¿í (KRIBB)
13:40-14:00 Applications of bio big data: Genomic analysis and precision medicine Ç¥°æÈ£ (¿¬¼¼´ë ÀÇ»ý¸í°øÇкÎ)
14:00-14:20 Bio big data analysis: Applications of machine learning and artificial intelligence ±èÅÂÇü (Å׶óÁ¨ÀÌÅؽº)
14:20-14:40 The future of bio big data: Challenges and opportunities ÀÌÁØÇÐ (KISTI)
14:40-15:00 Coffee Break
Session IV Plenary Session ÁøÀ±Å (°í·ÁÀÇ´ë), ÁÖ±¤·Î (°æÈñÀÇ´ë)
15:00-15:15 TBD
15:15-15:30 TBD
15:30-15:45 TBD
15:45-16:00 TBD
Session V-1 Free Paper Presentation I (Upper and lower GI) ¼Û±Ù¾Ï (ºÎ»êÀÇ´ë), ±Ýº¸¶ó(°í·ÁÀÇ´ë)
16:00-16:10 TBD
16:10-16:20 TBD
16:20-16:30 TBD
16:30-16:40 TBD
Session V-2 Free Paper Presentation II (Pancreas and bile duct) ÀÌ»óÇù (¼­¿ïÀÇ´ë), Á¶ÀçÈñ (¿¬¼¼ÀÇ´ë)
16:40-16:50 TBD
16:50-17:00 TBD
17:00-17:10 TBD
17:10-17:20 TBD
17:20-17:30 Best Presentation Award
17:30~ Adjournment ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ ÀÌ»çÀå ¹Ú¼±ÀÚ(°í½ÅÀÇ´ë)


´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Á¦20ȸ Ãá°èÇмú´ëȸ
Hall B
Session I Evidence-based Strategies for Managing Biliary Tract Cancers in Clinical Practice ȲÁøÇõ (¼­¿ïÀÇ´ë), ¹Úº´±Ô (±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø)
09:10-09:30 Pathological and molecular characteristics of biliary tract cancers, including ampullary cancer ³²ÁöÇØ (¿¬¼¼ÀÇ´ë)
09:30-09:50 Complexity of therapeutic approaches for advanced biliary tract cancers: Neo- and adjuvant treatment ÃÖÁ¤¿Ï (°í·ÁÀÇ´ë)
09:50-10:10 Therapeutic strategies for ampullary neoplasm: Lessons from Korean multicenter data registry À±½Â¹è (°¡Å縯ÀÇ´ë)
10:10-10:30 Precision medicine for biliary tract cancers °­È­Æò (°¡ÃµÀÇ´ë)
10:30-10:50 Coffee Break
Session II Integrative Approaches to Symptom Management for Gastrointestinal Cancer Patients ±è¼º¼ö (Ä«Å縯ÀÇ´ë), ±èµ¿¿í (Â÷ÀÇ°úÇдë)
10:50-11:10 Management for stress in gastrointestinal cancer patients Á¤¼®ÈÆ (¿ï»êÀÇ´ë)
11:10-11:30 Nutritional strategies for optimized care in gastrointestinal cancer patients ±è¼Ò¿µ (±¹¸³¾Ï¼¾ÅÍ)
11:30-11:50 Management options for sexual health in gastrointestinal cancer patients ±èµ¿¼ö (°æÈñÀÇ´ë)
11:50-12:10 Optimal care for oral health in gastrointestinal cancer patients ÀÌÈ¿Á¤ (ºÐ´ç¼­¿ï´ëÇб³º´¿ø Ä¡°ú)
12:20-12:40 »ç´Ü¹ýÀÎ °Ç°­»çȸ¸¦ À§ÇÑ ¼ÒÈ­±â¾Ï ¿¬±¸È¸ ÃÑȸ (Ãѹ«ÀÌ»ç È®ÀÎ ÇÊ¿ä)
12:40-13:20 ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ ÃÑȸ (Hall A)
Session III Grant-supported Research Session by KSGC ·ùÁö°ï (¼­¿ïÀÇ´ë), Á¤´ë¿µ (°¡Å縯ÀÇ´ë)
13:20-13:35 Cancer prevention through dietary and lifestyle modifications ÀÓÀ±Á¤ (µ¿±¹ÀÇ´ë)
13:35-13:50 Chemotherapy for elderly patients with pancreatic cancer: A systematic review and meta-analysis ½Åµ¿¿ì (ÇѸ²ÀÇ´ë)
13:50-14:05 Development of automated lymph node diagnosis technology for gastrointestinal cancers using ultra-large models ¾È»óÁ¤ (°í·ÁÀÇ´ë º´¸®°ú)
14:05-14:20 Microbial change in esophageal cancer: Pilot study Á¤°æ¿ø (°í½ÅÀÇ´ë)
14:20-14:35 Clinical characteristics and lifestyle factors associated with young age colorectal cancer in Korea: A multicenter prospective case-control study ¼ÒÀçÀº (¿¬¼¼ÀÇ´ë)
14:35-14:40 Q & A
14:40-15:00 Coffee Break
Session IV Beyond Life: Death, Records, and Responsibility ±èÇö¼ö (Àü³²ÀÇ´ë), ¹æ½Â¹Î (¿¬¼¼ÀÇ´ë)
16:00-16:40 Á×À½Àº ¼Ò¸êÀΰ¡? ¿Å°Ü°¨Àΰ¡? Á¤Çöä (¼­¿ïÀÇ´ë)
16:40-16:50 Q & A
16:50-17:10 Çö¸íÇÏ°í ¿Ã¹Ù¸¥ ÀÇ·á°¨Á¤¼­ ÀÛ¼ºÇϱâ-¼ÒÈ­±â³»°ú ÀÇ»ç °üÁ¡¿¡¼­ ÀÌÀμ® (°¡Å縯ÀÇ´ë)
17:10-17:20 Q & A
17:20-17:30 Best Presentation Award (Hall A)
17:30~ Adjournment (Hall A) ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ ÀÌ»çÀå ¹Ú¼±ÀÚ(°í½ÅÀÇ´ë)

Secretariat
´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ »ç¹«±¹
Tel : +82-2-313-7710
Fax : +82-2-313-7901
Email: gicancer@gicancer.or.kr